Literature DB >> 15310279

New non-nucleoside inhibitors of hepatitis C virus RNA-dependent RNA polymerase.

A V Ivanov1, M V Kozlov, A O Kuzyakin, D A Kostyuk, V L Tunitskaya, S N Kochetkov.   

Abstract

Recombinant RNA-dependent RNA polymerase of hepatitis C virus was purified using a bacterial expression system (Escherichia coli). The system for enzyme activity detection was optimized. The maximum activity was achieved when the reaction was carried out at 30 degrees C in the presence of 3 mM Mg2+ or 0.75 mM Mn2+. Among alpha- and beta-pyrogallaldehydes, effective inhibitors were found. It was shown that they acted at the primer elongation stage, and their binding to the protein is reversible.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15310279     DOI: 10.1023/b:biry.0000040204.82885.f1

Source DB:  PubMed          Journal:  Biochemistry (Mosc)        ISSN: 0006-2979            Impact factor:   2.487


  2 in total

1.  Label free inhibitor screening of hepatitis C virus (HCV) NS5B viral protein using RNA oligonucleotide.

Authors:  Changhyun Roh; Sang Eun Kim; Sung-Kee Jo
Journal:  Sensors (Basel)       Date:  2011-06-27       Impact factor: 3.576

2.  Effects of natural polymorphisms in SARS-CoV-2 RNA-dependent RNA polymerase on its activity and sensitivity to inhibitors in vitro.

Authors:  Nataliya Miropolskaya; Maxim Kozlov; Ivan Petushkov; Maria Prostova; Danil Pupov; Daria Esyunina; Sergey Kochetkov; Andrey Kulbachinskiy
Journal:  Biochimie       Date:  2022-10-14       Impact factor: 4.372

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.